Medpace Holdings, Inc. Reports First Quarter 2024 Results
- April 22, 2024
Revenue of $511.0 million in the first quarter of 2024 increased 17.7% from revenue of $434.1 million for the comparable prior-year period, representing a backlog conversion rate of 18.2%. Net new business awards were $615.6 million in the first quarter of 2024, representing an increase of 10.8%
Medpace Holdings, Inc. to Report First Quarter 2024 Financial Results on April 22, 2024
- March 28, 2024
CINCINNATI --(BUSINESS WIRE)--Mar. 28, 2024-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2024 financial results after the market close on Monday, April 22, 2024 . The Company will host a conference call the following morning, Tuesday,
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Results
- February 12, 2024
Revenue of $498.4 million in the fourth quarter of 2023 increased 26.5% from revenue of $394.1 million for the comparable prior-year period, representing a backlog conversion rate of 18.5%. Net new business awards were $614.7 million in the fourth quarter of 2023, representing an increase of 26.7%
Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 12, 2024
- January 3, 2024
CINCINNATI --(BUSINESS WIRE)--Jan. 3, 2024-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2023 financial results after the market close on Monday, February 12, 2024 . The Company will host a conference call the following